Call for your appointment today 914-666-4665 | Mt. Kisco, New York

  • All
  • All Things Lyme Hangout
  • Covid and Lyme Blog
  • Favorite Blogs
  • Lyme Disease Podcast
  • Lyme Science Blog
  • Uncategorized

Lyme Science Blog

Borrelia miyamotoi disease can be added to list of traveler’s concerns

Doctors described a case of BMD in a previously healthy 63-year-old American man living in Japan. “He reported being bitten by ticks several times while staying with his family at his summer house in the state of Minnesota in the USA from July 25 to August 9, 2013,” according to Oda from the Division of Infectious

Borrelia miyamotoi disease can be added to list of traveler’s concerns Read More »

Questions linger on the efficacy of the Lyme disease vaccine

The OspA vaccine trial was 78% effective at preventing a culture confirmed erythema migrans rash. But the vaccine was only 48% effective at preventing what the authors referred to as “possible Lyme disease.” “Possible Lyme disease was defined as a flu-like illness (fever, chills, fatigue, headache, joint or muscle aches) with IgM or IgG Western blot

Questions linger on the efficacy of the Lyme disease vaccine Read More »

NEUROLOGIC LYME DISEASE PATIENTS

Ever wonder what is happening in the brain of neurologic Lyme disease patients who remain ill after treatment?

by Daniel J. Cameron, MD MPH The authors found 13% of patients with a spinal tap positive by both cerebrospinal fluid pleocytosis and Borrelia-specific antibodies remained ill for more than 3 months after treatment. Meanwhile, 33% of Lyme neuroborreliosis patients with Borrelia-specific antibodies detected in cerebrospinal fluid and 43% of Lyme neuroborreliosis patients with pleocytosis

Ever wonder what is happening in the brain of neurologic Lyme disease patients who remain ill after treatment? Read More »

Borrelia burgdorferi activates human astrocytes cells in culture

by Daniel J. Cameron, MD MPH According to the authors, “If uncontrolled in the context of neuroborreliosis, the astrocyte response could lead to long-term injury in the CNS.” Researchers identified changes in gene expression within 48 hours of infecting cultured astrocytes with Borrelia burgdorferi (Bb). “Understanding how these changes are maintained over time will be

Borrelia burgdorferi activates human astrocytes cells in culture Read More »

What if a pronounced TH17 cytokine response in Lyme arthritis were caused by a persistent infection?

by Daniel J. Cameron, MD MPH According to a 2017 study published in Clinical Infectious Disease, a pronounced TH17 cytokine response may be beneficial in the early stages of Lyme disease. “In these patients, the levels of inflammatory mediators, particularly TH17-associated cytokines, correlated directly with B. burgdorferi IgG antibodies (P<0.02), suggesting a beneficial role for

What if a pronounced TH17 cytokine response in Lyme arthritis were caused by a persistent infection? Read More »

“Urban” ticks carry B. burgdorferi s.l. and B. miyamotoi

Questing ticks were collected from grassland, hedges, parks, woodland and woodland edges in Salisbury, an urban area located in Wiltshire, England. Ticks were identified at over 50% of the 25 sites surveyed. Furthermore, investigators reported that the collected ticks carried two pathogens posing a health risk to the public. The “DNA of Borrelia burgdorferi s.l.

“Urban” ticks carry B. burgdorferi s.l. and B. miyamotoi Read More »

Cochrane review failed to identify a single USA trial on the neurologic complications of Lyme disease

by Daniel J. Cameron, MD MPH In a review, published in Cochrane, entitled Antibiotics for the neurological complications of Lyme disease, Cadavid and colleagues identify several trials investigating the effectiveness of antibiotic treatments for neurological Lyme disease in Europe. The authors describe generally favorable outcomes for treating neurologic complications of Lyme disease. “The majority of people

Cochrane review failed to identify a single USA trial on the neurologic complications of Lyme disease Read More »